NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
- SEATTLE--(BUSINESS WIRE)-- #AGBT2024--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the CosMx™ Human 6K Discovery Panel, the industry's first single-cell spatial panel enabling research scientists to measure over 6,000 RNA targets, representing nearly every human biological pathway. Building on this breakthrough product developed for the CosMx Spatial Molecular Imager (SMI), Nan.
- 02/01/2024
|
NanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx™ Spatial Molecular Imager (SMI). The data will be highlighted at the 42nd annual J.P. Morgan Healthcare Conference 2024 in San Francisco during NanoString's corporate presentation on Wednesday, January 10, 20.
- 01/07/2024
|
NanoString Technologies to cut 9% of workforce, gets delisting notice from Nasdaq
- Seattle-based publicly traded biotech company NanoString Technologies said in a filing Friday that it plans to cut about 50 positions, or 9% of its workforce.
- 01/06/2024
|
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on December 6, 2023, the Compensation and Human Capital Committee of NanoString's Board of Directors approved the grant of, in the aggregate, 34,925 restricted stock units, or RSUs, as mat.
- 01/05/2024
|
NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 42nd annual J.P. Morgan healthcare conference, being held January 8-11, 2024. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, January 10, at 5:15pm ET. Interested parties can access the live webcast from the investor.
- 01/04/2024
|
7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight
- Playing in the field of nano-cap stocks is similar to the concept of stealing bases. In a tight baseball game, every advantage counts.
- 12/25/2023
|
NanoString Comments on Delaware District Court Verdict
- SEATTLE--(BUSINESS WIRE)--NanoString Comments on Delaware District Court Verdict.
- 11/19/2023
|
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies
- Jury Awards 10x Genomics Over $31 Million in Damages and Finds All Seven Asserted Patents Valid and Willfully Infringed by NanoString GeoMx Decision is Third Ruling Against NanoString, Showing Serial Infringement of 10x Patents PLEASANTON, Calif., Nov. 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the District of Delaware has reached a unanimous verdict in favor of 10x Genomics in the patent infringement suit 10x filed against the GeoMx products sold by NanoString Technologies, Inc. (Nasdaq: NSTG).
- 11/17/2023
|
NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience
- SEATTLE--(BUSINESS WIRE)--NanoString will present at the Society for Neuroscience meeting new brain research powered by its spatial profiling and spatial imaging platforms.
- 11/09/2023
|
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
- SEATTLE--(BUSINESS WIRE)--NanoString to present at November conferences.
- 11/09/2023
|
NanoString Technologies, Inc. (NSTG) Q3 2023 Earnings Call Transcript
- NanoString Technologies, Inc. (NASDAQ:NSTG ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Doug Farrell - IR Brad Gray - President and CEO Tom Bailey - CFO Conference Call Participants Marta Nazarovets - JPMorgan Kyle Boucher - TD Cowen Catherine Schulte - Baird Evan Stampler - Stifel Alexander Vukasin - Canaccord Genuity Operator Good afternoon. My name is Krista and I'll be your conference operator today.
- 11/06/2023
|
NanoString (NSTG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- While the top- and bottom-line numbers for NanoString (NSTG) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 11/06/2023
|
NanoString Technologies Releases Operating Results for Third Quarter of 2023
- SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString reports Q3 2023 Operating Results.
- 11/06/2023
|
Short squeeze alert for October 18th: 2 stocks that could soar
- In stock trading, shorting is seen as a high-risk, high-reward strategy. This approach involves borrowing stocks, selling them, and betting on their price dropping to make a profit.
- 10/18/2023
|
NanoString (NSTG) Grows in Translational Research With CRO Deals
- According to NanoString (NSTG), SMI's unique ability to interrogate both RNA and proteins at ultra-high plex with subcellular resolution has made it a one-of-a-kind tool.
- 09/12/2023
|
NanoString (NSTG) Advances in Xenotransplantation With New Study
- NanoString's (NSTG) nCounter Analysis System facilitates bulk tissue transcriptome profiling, revealing the intricacies of the immune response through the nCounter Human Organ Transplant Panel.
- 08/23/2023
|
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. 43rd Annual Canaccord Global Growth Conference Wednesday, August 9th Tom Bailey, NanoString's chief financial officer, and Doug Farrell, VP of Investor Relations, will participate in a fireside discussion hosted by Canaccord.
- 08/08/2023
|
NanoString Technologies, Inc. (NSTG) Q2 2023 Earnings Call Transcript
- NanoString Technologies, Inc. (NASDAQ:NSTG ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Doug Farrell - Vice President, Investor Relations & Corporate Communications Brad Gray - President & Chief Executive Officer Tom Bailey - Chief Financial Officer Conference Call Participants John Sourbeer - UBS Tom Peterson - Baird Operator Thank you for standing by. My name is Ian, and I will be your conference operator today.
- 08/03/2023
|
Helen of Troy and NanoString Technologies Trade Set-ups
- The action is hot in Helen Of Troy NASDAQ: HELE and NanoString Technologies NASDAQ: NSTG. These unrelated companies issued better-than-expected results and guidance that have their shares up double-digits in early trading.
- 07/10/2023
|
Red-Hot Quality Opportunities in Genomics
- The health care sector is currently undergoing a remarkable transformation. The recent focus on genomics has empowered medical professionals to diagnose patients more objectively and adopt proactive measures to maintain the well-being of larger populations.
- 06/22/2023
|
NanoString to Webcast Presentation from Jefferies Healthcare Conference
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Jefferies Healthcare Conference, which will be held June 7-9, 2023. Brad Gray, president and chief executive officer, is scheduled to present on Thursday, June 8, 2023, at 8:30am ET. Interested parties can access the live webcast from the investor section o.
- 05/31/2023
|
NanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of Munich
- SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will host a conference call on Monday, May 22, 2023, at 4:30pm ET to provide an update on the recent Decision of the Regional Court of Munich. Investors and other interested parties should register for the conference call in advance by visiting https://www.netroadshow.com/events/login?show=9b96aaa1&confId=5.
- 05/22/2023
|
Why Shares of NanoString Technologies Are Falling Thursday
- NanoString Technologies may have to stop selling certain instruments and reagents in Germany. The company said it plans to appeal the ruling.
- 05/18/2023
|
NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates
- NanoString Technologies (NSTG) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $0.86 per share a year ago.
- 05/03/2023
|
NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023
- SEATTLE--(BUSINESS WIRE)--NanoString to report Q1 2023 operating results on May 3, 2023.
- 04/10/2023
|
NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, “AI-Driven Disruptions To Genomics & Computational Drug Discovery”, from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023.
- 03/01/2023
|
NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates
- NanoString (NSTG) delivered earnings and revenue surprises of -55.74% and 3.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/28/2023
|
NanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023. Brad Gray, president and chief executive officer, is scheduled to present on Tuesday, March 7, 2023, at 1:30pm ET.
- 02/23/2023
|
NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
- SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report fourth quarter and fiscal year 2022 operating results after the close of the market on Tuesday, February 28, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.
- 02/14/2023
|
NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference
- SEATTLE--( BUSINESS WIRE )--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company's management is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference.
- 12/22/2022
|
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences
- SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.
- 11/10/2022
|
NanoString Technologies (NSTG) Reports Q3 Loss, Misses Revenue Estimates
- NanoString (NSTG) delivered earnings and revenue surprises of -71.74% and 16.66%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/07/2022
|
NanoString to Release Third Quarter 2022 Operating Results and Host Conference Call on Monday, November 7, 2022
- SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report third quarter 2022 operating results after the close of the market on Monday, November 7, 2022.
- 10/12/2022
|
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
- SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming financial conferences. Morgan Stanley 20th Annual Global Healthcare Conference Monday, September 12th Brad Gray, NanoString's chief executive officer, will participate in a fireside discussion at 1:05pm ET. 2022 Baird Global Healthcare Conference Tu
- 09/07/2022
|
NanoString Technologies, Inc.'s (NSTG) CEO Brad Gray on Q2 2022 Earnings Call Transcript
- NanoString Technologies, Inc. (NASDAQ:NSTG ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Doug Farrell - Vice President, Investor Relations Brad Gray - President and Chief Executive Officer Tom Bailey - Chief Financial Officer Conference Call Participants Alex Vukasin - Canaccord Genuity Dan Brennan - Cowen Edmund Debler - Morgan Stanley Dan Arias - Stifel Operator Hello and welcome to the NanoString Second Quarter Operating Results. My name is Katie, and I'll be coordinating your call today.
- 08/06/2022
|
NanoString Technologies (NSTG) Reports Q2 Loss, Lags Revenue Estimates
- NanoString (NSTG) delivered earnings and revenue surprises of -37.10% and 0.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2022
|
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences
- SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. 42nd Annual Canaccord Global Growth Conference Wednesday, August 10th Brad Gray, NanoString's chief executive officer, will participate in a spatial biology panel titled, “The New Frontier of Life Sciences: Spatial Omics is T
- 08/04/2022
|
Wall Street Analysts See a 172% Upside in NanoString (NSTG): Can the Stock Really Move This High?
- The consensus price target hints at a 171.7% upside potential for NanoString (NSTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- 07/21/2022
|
NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022
- SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report second quarter 2022 operating results after the close of the market on Thursday, August 4, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update. Investors and other interested parties should register for the conference cal
- 07/11/2022
|
NanoString to Webcast Presentation from the UBS 2022 Global Healthcare Conference
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 2022 UBS Global Healthcare Conference. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, May 25, 2022, at 9:15 am ET. Interested parties can access the live webcast with accompanying slides from the investor section of
- 05/18/2022
|
NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2022 Earnings Call Transcript
- NanoString Technologies, Inc. Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Doug Farrell - VP of IR & Corporate Communications Brad Gray - CEO, President & Director Tom Bailey - CFO Conference Call Participants Daniel Brennan - Cowen Dan Arias - Stifel Julia Qin - JPMorgan Kyle Mikson - Canaccord Genuity Catherine Schulte - Robert W. Baird Tejas Savant - Morgan Stanley Operator Hello.
- 05/10/2022
|
NanoString to Release First Quarter 2022 Operating Results and Host Conference Call on Tuesday, May 10, 2022
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2022 operating results after the close of the market on Tuesday, May 10, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update. Investors and other interested parties should register for the conference call in
- 04/27/2022
|
NanoString stock plunges after revenue warning, but analyst says selloff appears 'way overdone'
- Shares of NanoString Technologies Inc. ntsg plunged 32.8% toward a two-year low in morning trading Wednesday, enough to make them the biggest losers trading on major U.S. exchanges, after the provider of life science discovery tools warned about a revenue miss, citing execution missteps. The company said late Tuesday that it now expects first-quarter product and service revenue of $31 million, below the previously provided guidance range of $34 million to $38 million.
- 04/13/2022
|
Does NanoString (NSTG) Have the Potential to Rally 117% as Wall Street Analysts Expect?
- The mean of analysts' price targets for NanoString (NSTG) points to an 116.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- 04/06/2022
|
NanoString Technologies' (NSTG) CEO Brad Gray on Q4 2021 Earnings Call Transcript
- NanoString Technologies' (NSTG) CEO Brad Gray on Q4 2021 Earnings Call Transcript
- 03/01/2022
|
NanoString to Webcast Presentation from the 11th Annual SVB Leerink Global Healthcare Conference
- SEATTLE--(BUSINESS WIRE)--NanoString to present at 11th Annual SVB Leerink Healthcare Conference.
- 02/09/2022
|
NanoString Expects Q4 Product And Service Revenue Growth Of 18%
- NanoString Technologies Inc (NASDAQ: NSTG) expects Q4 FY21 product and service revenue of approximately $42 million, +18% Y/Y and at the upper end of the company's guidance of $38 million - $42 million. For FY21, the company expects product and service revenue to be approximately $144 million, +29% YY and at the upper end of the company's prior guidance of $140 million - $144 million.
- 01/10/2022
|
NanoString Technologies' Q3 Fall Short Street View; Cuts FY21 Guidance
- NanoString Technologies Inc (NASDAQ: NSTG) reported Q3 sales of $37.15 million, +17% Y/Y, mainly driven by instrument sales, demand for consumables, and services. Q3 sales fell slightly short of analysts' consensus estimate of $37.79 million.
- 11/10/2021
|
NanoString to Webcast Presentation from the Stifel 2021 Virtual Healthcare Conference
- SEATTLE--(BUSINESS WIRE)--NanoString to present at the 2021 Stifel Virtual Healthcare Conference.
- 11/10/2021
|
NanoString Technologies' (NSTG) CEO Brad Gray on Q3 2021 Results - Earnings Call Transcript
- NanoString Technologies' (NSTG) CEO Brad Gray on Q3 2021 Results - Earnings Call Transcript
- 11/09/2021
|
NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments
- SEATTLE--(BUSINESS WIRE)--NanoString announces the launch of the nCounter® ADC Development Panel.
- 10/12/2021
|
NanoString to Release Third Quarter 2021 Operating Results and Host Conference Call on Tuesday, November 9, 2021
- SEATTLE--(BUSINESS WIRE)--NanoString to host third quarter 2021 operating results webcast on Tuesday, November 9th, 2021.
- 10/06/2021
|
NanoString to Webcast Presentation from the 19th Annual Morgan Stanley Global Healthcare Conference
- SEATTLE--(BUSINESS WIRE)--NanoString to present at Morgan Stanley Global Healthcare Conference.
- 09/01/2021
|
NanoString's GeoMx Digital Spatial Profiling Platform Reveals Insights Into the Immune Landscape of Cancer in Publication in the Journal Cell
- SEATTLE--(BUSINESS WIRE)--NanoString announced a peer-reviewed publication using the GeoMx® Digital Spatial Profiler (DSP), published in the journal Cell.
- 08/31/2021
|
NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q2 2021 Results - Earnings Call Transcript
- NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q2 2021 Results - Earnings Call Transcript
- 08/04/2021
|
NanoString to Release Second Quarter 2021 Operating Results and Host Conference Call on Wednesday, August 4, 2021
- SEATTLE--(BUSINESS WIRE)--NanoString to report second quarter 2021 operating results and host conference call on Wednesday, August 4th.
- 07/08/2021
|
NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® Stem Cell Characterization Panel for the analysis and optimization of stem cell lines used in the development of potential novel therapeutics. Recent breakthroughs in stem cell therapy, regenerative medicine, and CRISPR engineering have advanced the development of promising new treatments for debili
- 06/22/2021
|
NanoString: Compelling Upside For This Spatial Biology Instrument Developer
- NanoString Technologies, Inc. is a genomics/proteomics-focused developer of advanced instruments and consumables for scientific and clinical research. NanoString's products consist of two commercially available product platforms, the nCounter Analysis System (launched in 2008) and the GeoMx Digital Spatial Profiler System ("DSP" launched in 2019).
- 06/17/2021
|
NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer
- SEATTLE & SAN FRANCISCO--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and the Parker Institute for Cancer Immunotherapy (PICI) announced today that they are collaborating on an expansive molecular characterization project for cellular therapies. The collaboration will define the characteristics that make a cell therapy effective, providing a standardized approach to developing CAR-T regimens tha
- 06/15/2021
|
NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference
- SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the Jefferies Virtual Healthcare conference.
- 05/27/2021
|
Down More Than 20%, Is This Cathie Wood Biotech A Buy?
- 10x Genomics stock has fallen, despite announcing strong first-quarter numbers.
- 05/20/2021
|
NanoString to Webcast Presentation from the UBS Global Healthcare Conference
- SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the UBS Global Healthcare Conference.
- 05/20/2021
|
NanoString's GeoMx Mouse Whole Transcriptome Atlas Expands Leadership in Spatial Genomics by Enabling Genome-Wide RNA Profiling
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the Mouse Whole Transcriptome Atlas (WTA) for spatial analysis research using the GeoMx® Digital Spatial Profiler (DSP). This launch extends the GeoMx RNA portfolio, which combines the power of spatial biology and Next Generation Sequencing (NGS), to enable full transcriptome spatial RNA and high
- 05/17/2021
|
NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2021 Results - Earnings Call Transcript
- NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2021 Results - Earnings Call Transcript
- 05/11/2021
|
NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates
- NanoString (NSTG) delivered earnings and revenue surprises of -6.90% and 5.19%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/10/2021
|
Medical Product Stock Q1 Earnings on May 10: MRVI, TGTX & More
- The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.
- 05/07/2021
|
NanoString's Digital Spatial Profiling Platform Used to Create Foundational Dataset Revealing Insights into COVID-19
- SEATTLE--(BUSINESS WIRE)--NanoString announced today that a peer-reviewed publication using the GeoMx® Digital Spatial Profiler is to be published in the journal Nature.
- 05/04/2021
|
NanoString Highlights Spatial Biology Research from the 2021 American Association of Cancer Research (AACR) Conference
- SEATTLE--(BUSINESS WIRE)--NanoString announces spatial biology highlights from the 2021 American Association of Cancer Research Conference.
- 04/08/2021
|
NanoString's GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications
- SEATTLE--(BUSINESS WIRE)--NanoString's GeoMx DSP reveals insights into COVID-19 in two new publications in Nature.
- 03/31/2021
|
Top Shorts Today As Stocks Recover From Yesterday's Sell-Off
- After the market sold off on the first anniversary of the bull market yesterday, investors saw renewed signs of recovery. Meanwhile, the deep learning algorithms at Q.ai have crunched the data to give you today's top shorts.
- 03/24/2021
|
NanoString, Illumina Accelerator and Doloromics Announce GeoMx Digital Spatial Profiling Collaboration to Develop Novel Pain Therapeutics
- SEATTLE--(BUSINESS WIRE)-- #spatialbiology--NanoString enters spatial biology collaboration with Illumina Accelerator and Doloromics.
- 03/22/2021
|
Top Stocks To Short Today As Nasdaq Pops Again
- Just as quickly as Nasdaq NDAQ hit correction territory twice in the last week, it saw sharp gains. Meanwhile, Q.ai's deep learning algorithms have brought you today's top shorts.
- 03/11/2021
|
NanoString Appoints Dr. Dana Rollison and Janet George to Board of Directors
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies announced the appointment of two new board members, Dr. Dana Rollison and Janet George, effective March 8, 2021.
- 03/09/2021
|
Top Stocks To Short Today As The Rotation Into Recovery Continues
- The rotation into recovery continues as President Biden's stimulus proposal passed through the Senate. To make the most of this market, Q.ai's Artificial Intelligence has assessed each firm to find today's top short plays.
- 03/08/2021
|
NanoString Technologies, Inc. (NSTG) CEO Bradley Gray on Q4 2020 Results - Earnings Call Transcript
- NanoString Technologies, Inc. (NSTG) CEO Bradley Gray on Q4 2020 Results - Earnings Call Transcript
- 03/02/2021
|
NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates
- NanoString (NSTG) delivered earnings and revenue surprises of -12.77% and 1.72%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 03/01/2021
|
NanoString Technologies Releases Fourth Quarter and Full Year 2020 Operating Results and Provides 2021 Financial Outlook
- SEATTLE--(BUSINESS WIRE)--NanoString releases Q4 and FY20 operating results.
- 03/01/2021
|
NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference
- SEATTLE--(BUSINESS WIRE)--NanoString announces highlights of 2021 Advances in Genome Biology and Technology conference.
- 03/01/2021
|
A Preview Of NanoString Technologies's Earnings
- NanoString Technologies (NASDAQ:NSTG) unveils its next round of earnings this Monday, March 01. Get prepared with Benzinga's ultimate preview for NanoString Technologies's Q4 earnings.
- 02/26/2021
|
NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference
- SEATTLE--(BUSINESS WIRE)--NanoString to present at the 41st annual Cowen healthcare conference.
- 02/24/2021
|
Earnings Preview: NanoString Technologies (NSTG) Q4 Earnings Expected to Decline
- NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/22/2021
|
NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021
- SEATTLE--(BUSINESS WIRE)--NanoString announces launch of GeoMx DSP Whole Transcriptome Atlas.
- 02/22/2021
|
NanoString to Webcast Presentation from the 10th Annual SVB Leerink Global Healthcare Conference
- SEATTLE--(BUSINESS WIRE)--NanoString to present at 10th Annual SVB Leerink conference.
- 02/17/2021
|
Nature Medicine Publishes First Study Utilizing NanoString's GeoMx Digital Spatial Profiler Whole Transcriptome Atlas
- SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in the journal Nature Medicine that used NanoString's GeoMx® Digital Spatial Profiler (DSP) and the new Whole Transcriptome Atlas (WTA) to profile sarcoma tissue. The research was led by a team from the Broad Institute in Cambridge, Massachusetts. The paper, entitled “Opposing immune and genetic mecha
- 02/09/2021
|
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020
- SEATTLE--(BUSINESS WIRE)--NanoString provides preliminary financial and operational highlights for Q4'20.
- 01/10/2021
|
NanoString's GeoMx Digital Spatial Profiler Identifies Diverse Immune Responses Within COVID-19 Patients in Study Published in Nature Communications
- SEATTLE--(BUSINESS WIRE)--NanoString's GeoMx DSP Identifies Diverse Immune Responses in COVID-19 Patients.
- 12/09/2020
|
NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology
- SEATTLE--(BUSINESS WIRE)--NanoString announces development of spatial molecular imaging platform.
- 12/01/2020
|
NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC)
- SEATTLE--(BUSINESS WIRE)--NanoString announces research highlights from SITC 2020.
- 11/11/2020
|
NanoString Technologies, Inc. (NSTG) CEO Bradley Gray on Q3 2020 Results - Earnings Call Transcript
- NanoString Technologies, Inc. (NSTG) CEO Bradley Gray on Q3 2020 Results - Earnings Call Transcript
- 11/10/2020
|
NanoString Technologies: Q3 Earnings Insights
- Shares of NanoString Technologies (NASDAQ:NSTG) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 1.56% over the past year to ($0.65), which missed the estimate of ($0.60).
- 11/09/2020
|
NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing
- SEATTLE--(BUSINESS WIRE)--NanoString announces commercial launch of spatially resolved protein analysis using next generation sequencing.
- 11/09/2020
|
K Thomas Bailey Sells 5,938 Shares of NanoString Technologies Inc (NASDAQ:NSTG) Stock
- NanoString Technologies Inc (NASDAQ:NSTG) CFO K Thomas Bailey sold 5,938 shares of NanoString Technologies stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $38.94, for a total transaction of $231,225.72. Following the sale, the chief financial officer now directly owns 5,938 shares of the company’s stock, valued […]
- 08/22/2020
|
10x Genomics Enjoys Investor Support As Stock Rebounds
- 10x Genomics went public in September 2019. The firm provides equipment and software for genetic research purposes.
- 08/14/2020
|
Is NanoString Technologies (NASDAQ:NSTG) A Risky Investment?
- Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- 08/11/2020
|
Did You Miss NanoString Technologies' (NASDAQ:NSTG) Impressive 151% Share Price Gain?
- It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
- 08/11/2020
|
NanoString Technologies (NSTG) Reports Q2 Loss, Tops Revenue Estimates
- NanoString (NSTG) delivered earnings and revenue surprises of -28.57% and 40.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/10/2020
|
NanoString Technologies Releases Operating Results for Second Quarter of 2020
- NanoString Technologies Releases Operating Results for Second Quarter of 2020
- 08/10/2020
|
NanoString Technologies Releases Operating Results for Second Quarter of 2020
- NanoString Technologies Releases Operating Results for Second Quarter of 2020
- 08/10/2020
|
NanoString Technologies Inc (NASDAQ:NSTG) Expected to Announce Quarterly Sales of $16.15 Million
- Analysts expect NanoString Technologies Inc (NASDAQ:NSTG) to post $16.15 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for NanoString Technologies’ earnings, with estimates ranging from $13.66 million to $18.78 million. NanoString Technologies reported sales of $30.35 million in the same quarter last year, which would suggest […]
- 08/09/2020
|
Medical Products Stock Earnings on Aug 10: CGC, SDGR & More
- Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.
- 08/07/2020
|
NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler
- NanoString Expands RNAscope Partnership with Bio-Techne's ACD Division.
- 08/06/2020
|
NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler
- NanoString Expands RNAscope Partnership with Bio-Techne's ACD Division.
- 08/06/2020
|
Were Hedge Funds Right About Buying NanoString Technologies Inc (NSTG)?
- The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. Now, we are […]
- 08/05/2020
|
Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know
- NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 08/03/2020
|
NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers
- NanoString announces next generation sequencing read-out for the GeoMx Digital Spatial Profiler.
- 08/03/2020
|
NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers
- NanoString announces next generation sequencing read-out for the GeoMx Digital Spatial Profiler.
- 08/03/2020
|
NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
- NanoString Announces Second Quarter Conference Call
- 07/08/2020
|
NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
- NanoString Announces Second Quarter Conference Call
- 07/08/2020
|
NanoString Technologies (NSTG) Surges: Stock Moves 10.3% Higher
- NanoString Technologies (NSTG) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
- 07/02/2020
|
Global Digital Genome Market Forecast to 2027 - COVID-19 Impact and Analysis by Product, Application, End-user, Geography and Company - ResearchAndMarkets.com
|
Hedge Funds Getting Crazy About NanoString Technologies Inc (NSTG)
- At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]
- 06/23/2020
|
Two Sigma Investments LP Has $1.23 Million Stake in NanoString Technologies Inc (NASDAQ:NSTG)
- Two Sigma Investments LP grew its stake in NanoString Technologies Inc (NASDAQ:NSTG) by 12.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,247 shares of the biotechnology company’s stock after purchasing an additional 5,687 shares during the period. Two Sigma Investments LP […]
- 06/22/2020
|
Arch Oncology Announces Formation of Scientific Advisory Board
- Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of best-in-class anti-CD47 antibody therapies,
- 06/22/2020
|
NanoString Technologies Inc (NASDAQ:NSTG) Shares Purchased by Nuveen Asset Management LLC
- Nuveen Asset Management LLC boosted its holdings in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 107.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 553,845 shares of the biotechnology company’s stock after acquiring an additional 286,968 shares during the […]
- 06/20/2020
|
NanoString Technologies : Announces New Products to Advance COVID-19 Disease Research | MarketScreener
|
NanoString Announces New Products to Advance COVID-19 Disease Research
- NanoString announces new COVID-19 research tools.
- 06/16/2020
|
NanoString Announces New Products to Advance COVID-19 Disease Research
- NanoString announces new COVID-19 research tools.
- 06/16/2020
|
Edited Transcript of NSTG earnings conference call or presentation 7-May-20 8:30pm GMT
- Q1 2020 NanoString Technologies Inc Earnings Call
- 06/10/2020
|
Acadian Asset Management LLC Sells 86,291 Shares of NanoString Technologies Inc (NASDAQ:NSTG)
- Acadian Asset Management LLC decreased its position in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 96.6% in the 1st quarter, HoldingsChannel reports. The fund owned 3,069 shares of the biotechnology company’s stock after selling 86,291 shares during the period. Acadian Asset Management LLC’s holdings in NanoString Technologies were worth $74,000 as of its most recent […]
- 06/10/2020
|
Global Precision Medicine Market Report 2020: Historic Analysis and Outlook 2015-2025 - ResearchAndMarkets.com
|
NanoString, OnRamp Reports Partnership To Develop Cloud-Based Analysis Solutions For nCounter Data
|
NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data
- NanoString and OnRamp Partner to Develop Cloud-Based Analysis Solutions for nCounter Data.
- 05/20/2020
|
21 Risky Stocks That Might Have Borrowed More Than Is Good For Them
- Monetary and fiscal stimulus has reopened the credit markets even for companies that have seen their businesses get hit hard by coronavirus. That large debt load relative to earnings could cause problems down the road.
- 05/19/2020
|
21 Stocks That Might Have Borrowed More Than Is Good For Them
- Monetary and fiscal stimulus has reopened the credit markets even for companies that have seen their businesses get hit hard by coronavirus. That large debt load relative to earnings could cause problems down the road
- 05/19/2020
|
NanoString to Present at the UBS Global Healthcare Conference
- NanoString to present at the UBS Global Healthcare Conference.
- 05/14/2020
|
CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
- CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
- 05/14/2020
|
Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research
- NanoString Highlights Recent Publications that Demonstrate the Performance of the GeoMx DSP.
- 05/12/2020
|
Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research
- NanoString Highlights Recent Publications that Demonstrate the Performance of the GeoMx DSP.
- 05/12/2020
|
NanoString to Present at the Bank of America Health Care Conference
- NanoString to present at the Bank of America Health Care Conference.
- 05/11/2020
|
NanoString to Present at the Bank of America Health Care Conference
- NanoString to present at the Bank of America Health Care Conference.
- 05/11/2020
|
NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2020 Results - Earnings Call Transcript
- Start Time: 16:30 End Time: 17:21 NanoString Technologies, Inc. (NASDAQ:NSTG) Q1 2020 Earnings Conference Call May 07, 2020, 16:30 PM ET Company Participants Br
- 05/10/2020
|
Nanostring Technologies (NSTG) Q1 2020 Earnings Call Transcript
- Ladies and gentlemen, thank you for standing by, and welcome to the NanoString first-quarter 2020 operating results conference call. Joining me on the call today is Brad Gray, our president and CEO; and Tom Bailey, our CFO.
- 05/09/2020
|
Edited Transcript of NSTG earnings conference call or presentation 7-May-20 8:30pm GMT
- Q1 2020 NanoString Technologies Inc Earnings Call
- 05/08/2020
|
NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates
- NanoString (NSTG) delivered earnings and revenue surprises of -34.69% and 7.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 05/07/2020
|
NanoString Technologies Q1 EPS $(1.040) May Not Compare To $(0.520) Estimate, Sales $24.500M Miss $25.420M Estimate
|
NanoString Technologies Releases Operating Results for First Quarter of 2020
- NanoString reports first quarter 2020 operating results.
- 05/07/2020
|
What will the Oracle say?
- News is free at Seeking Alpha.This post is a Notable Call. Notable Calls are a Premium feature.To access this and other Notable Calls, try a free trial to Seeking Alpha Premium.
- 05/01/2020
|
NanoString Technologies Inc (NASDAQ:NSTG) Receives $33.25 Consensus PT from Brokerages
- NanoString Technologies Inc (NASDAQ:NSTG) has been given an average rating of “Buy” by the six brokerages that are presently covering the company, MarketBeat reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokerages that have […]
- 05/01/2020
|
Columbus Circle Investors Increases Stock Holdings in NanoString Technologies Inc (NASDAQ:NSTG)
- Columbus Circle Investors lifted its position in NanoString Technologies Inc (NASDAQ:NSTG) by 1,082.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 262,704 shares of the biotechnology company’s stock after buying an additional 240,480 shares during the quarter. Columbus […]
- 04/30/2020
|
UBS Maintains Buy on NanoString Technologies, Lowers Price Target to $38
|
Stock Upgrades: NanoString Technologies Shows Rising Relative Strength
|
NanoString Technologies Inc (NASDAQ:NSTG) Director Sells $45,000.00 in Stock
- NanoString Technologies Inc (NASDAQ:NSTG) Director Kirk Malloy sold 1,500 shares of the company’s stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $30.00, for a total value of $45,000.00. Following the transaction, the director now directly owns 1,500 shares in the company, valued at $45,000. […]
- 04/24/2020
|
NanoString Technologies Inc (NASDAQ:NSTG) Director Sells $25,610.00 in Stock
- NanoString Technologies Inc (NASDAQ:NSTG) Director Kirk Malloy sold 1,000 shares of the firm’s stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $25.61, for a total value of $25,610.00. Following the completion of the transaction, the director now owns 1,000 shares of the company’s stock, valued at […]
- 04/20/2020
|
NanoString Technologies Earns Relative Strength Rating Upgrade
|
Conestoga Capital Advisors LLC Acquires 625 Shares of NanoString Technologies Inc (NASDAQ:NSTG)
- Conestoga Capital Advisors LLC boosted its holdings in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 2.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,395 shares of the biotechnology company’s stock after acquiring an additional 625 shares during […]
- 04/19/2020
|
Geode Capital Management LLC Grows Position in NanoString Technologies Inc (NASDAQ:NSTG)
- Geode Capital Management LLC lifted its position in NanoString Technologies Inc (NASDAQ:NSTG) by 3.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 451,011 shares of the biotechnology company’s stock after purchasing an additional 15,351 shares during the period. Geode […]
- 04/19/2020
|
Exchange Traded Concepts LLC Has $82,000 Stock Position in NanoString Technologies Inc (NASDAQ:NSTG)
- Exchange Traded Concepts LLC increased its position in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 23.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,389 shares of the biotechnology company’s stock after purchasing an additional 649 shares during the quarter. Exchange Traded […]
- 04/16/2020
|
NanoString Earlier Reported First Publication Utilizing nCounter Platform For Measuring Immune Response In Coronavirus Research
|
Singapore Researchers Use NanoString’s nCounter Platform to Rapidly Profile the Response of the Immune System to the SARS-CoV-2 Virus
- NanoString highlights nCounter publication in COVID-19 research.
- 04/15/2020
|
$25.51 Million in Sales Expected for NanoString Technologies Inc (NASDAQ:NSTG) This Quarter
- Wall Street brokerages expect that NanoString Technologies Inc (NASDAQ:NSTG) will announce $25.51 million in sales for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for NanoString Technologies’ earnings, with the highest sales estimate coming in at $26.49 million and the lowest estimate coming in at $24.53 million. NanoString Technologies posted sales of […]
- 04/15/2020
|
Global Spatial Genomics & Transcriptomics Market Study, 2020-2025 - ResearchAndMarkets.com
- The "Spatial Genomics & Transcriptomics Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering.
- 04/15/2020
|
Stock Upgrades: NanoString Technologies Shows Rising Relative Strength
|
Spatial Genomics & Transcriptomics Markets, Forecast to 2025 - Emerging Potential of Spatial Genomic Analysis as a Cancer Diagnostic Tool
- The "Spatial Genomics & Transcriptomics Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering.
- 04/14/2020
|
Bank of New York Mellon Corp Has $8.63 Million Stake in NanoString Technologies Inc (NASDAQ:NSTG)
- Bank of New York Mellon Corp raised its position in NanoString Technologies Inc (NASDAQ:NSTG) by 56.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 310,189 shares of the biotechnology company’s stock after purchasing an additional 111,957 shares during the quarter. Bank of New […]
- 04/13/2020
|
Man Group plc Reduces Stake in NanoString Technologies Inc (NASDAQ:NSTG)
- Man Group plc cut its stake in NanoString Technologies Inc (NASDAQ:NSTG) by 89.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,766 shares of the biotechnology company’s stock after selling 95,365 shares during the quarter. Man Group plc’s holdings in NanoString Technologies […]
- 04/12/2020
|
NanoString Technologies Inc (NASDAQ:NSTG) Shares Bought by Goldman Sachs Group Inc.
- Goldman Sachs Group Inc. boosted its position in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 28.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 114,295 shares of the biotechnology company’s stock after purchasing an additional 25,503 shares during the […]
- 04/12/2020
|
False advertising: They call it the ‘Amazon tax,’ but it’s so much more
- The $500 million a year "Amazon tax" before the Seattle City Council would also likely hit some firms in the health sector that are working on the front lines of the coronavirus pandemic.
- 04/11/2020
|
NanoString Technologies Inc (NASDAQ:NSTG) Holdings Trimmed by AQR Capital Management LLC
- AQR Capital Management LLC trimmed its position in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 79.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 21,637 shares of the biotechnology company’s stock after selling 81,870 shares during the period. AQR Capital Management LLC owned […]
- 04/10/2020
|
Stock Upgrades: NanoString Technologies Shows Rising Relative Strength
|
NanoString Tech (NSTG) Gets a Buy Rating from Robert W. Baird
- In a report released today, Catherine Ramsey Schulte from Robert W. Baird maintained a Buy rating on NanoString Tech (NSTG), with a price target of
- 04/07/2020
|
NanoString Tech (NSTG) Gets a Buy Rating from Robert W. Baird
- In a report released today,
Catherine Ramsey Schulte
from Robert W. Baird maintained a
Buy
rating on NanoString Tech (
NSTG
–
Research Report
), with a price target of
$29.00
. The company’s shares closed last Tuesday at $25.00.
According to
TipRanks
- 04/07/2020
|
Baird Maintains Outperform on NanoString Technologies, Lowers Price Target to $29
|
Downgrade: Here's How Analysts See NanoString Technologies, Inc. (NASDAQ:NSTG) Performing In The Near Term
- Market forces rained on the parade of NanoString Technologies, Inc. (NASDAQ:NSTG) shareholders today, when the...
- 04/07/2020
|
Bearish: Analysts Just Cut Their NanoString Technologies, Inc. (NASDAQ:NSTG) Revenue and EPS estimates
- The analysts covering NanoString Technologies, Inc. (NASDAQ:NSTG) delivered a dose of negativity to shareholders...
- 04/07/2020
|
NanoString Withdraws FY20 Guidance
|
NanoString Reports 15+ New GeoMx DSP Instrument Orders In Q1
|
NanoString Reports Its nCounter Instrument, Consumable Sales Have Been Disrupted By Coronavirus Pandemic
|
NanoString Reports GeoMx DSP Orders, Sales Inline With Prior Guidance
|
NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020
- NanoString provides COVID-19 business update.
- 04/06/2020
|
Credit Suisse AG Reduces Stock Position in NanoString Technologies Inc (NASDAQ:NSTG)
- Credit Suisse AG reduced its position in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 44.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,681 shares of the biotechnology company’s stock after selling 16,519 shares during the period. Credit Suisse AG owned […]
- 04/06/2020
|
Stocks Showing Rising Market Leadership: NanoString Technologies Earns 81 RS Rating
|
Critical Survey: NanoString Technologies (NASDAQ:NSTG) versus AVITA MED LTD/S (NASDAQ:AVMXY)
- NanoString Technologies (NASDAQ:NSTG) and AVITA MED LTD/S (OTCMKTS:AVMXY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Valuation & Earnings This table compares NanoString Technologies and AVITA MED LTD/S’s top-line revenue, […]
- 04/03/2020
|
Stifel Maintains Buy on NanoString Technologies, Lowers Price Target to $35
|
Why NanoString Technologies (NSTG) Stock Might be a Great Pick
- NanoString Technologies (NSTG) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- 03/27/2020
|
Why NanoString Technologies (NSTG) Stock Might be a Great Pick
- NanoString Technologies (NSTG) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- 03/27/2020
|
Investors Buy Large Volume of NanoString Technologies Call Options (NASDAQ:NSTG)
- NanoString Technologies Inc (NASDAQ:NSTG) was the target of unusually large options trading on Thursday. Investors acquired 1,491 call options on the stock. This represents an increase of 1,614% compared to the average daily volume of 87 call options. Several research firms have commented on NSTG. BidaskClub upgraded NanoString Technologies from a “buy” rating to a […]
- 03/27/2020
|
NanoString Technologies (NASDAQ:NSTG) Upgraded to Strong-Buy by BidaskClub
- NanoString Technologies (NASDAQ:NSTG) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued on Friday, BidAskClub reports. Other equities analysts have also recently issued reports about the stock. ValuEngine upgraded shares of NanoString Technologies from a “hold” rating to a “buy” rating in a […]
- 03/27/2020
|
NanoString Technologies Joins Elite Club Of Stocks With RS Ratings Over 90
|
NanoString Technologies Scores Relative Strength Rating Upgrade; Hits Key Threshold
|
NanoString Technologies (NASDAQ:NSTG) Stock Price Up 16%
- NanoString Technologies Inc (NASDAQ:NSTG)’s stock price rose 16% on Tuesday . The stock traded as high as $21.95 and last traded at $21.62, approximately 627,800 shares traded hands during trading. A decline of 1% from the average daily volume of 636,725 shares. The stock had previously closed at $18.63. NSTG has been the topic of […]
- 03/25/2020
|
IBD Rating Upgrades: NanoString Technologies Flashes Improved Relative Price Strength
|
Citigroup Inc. Grows Stake in NanoString Technologies Inc (NASDAQ:NSTG)
- Citigroup Inc. lifted its position in NanoString Technologies Inc (NASDAQ:NSTG) by 19.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,741 shares of the biotechnology company’s stock after buying an additional 1,891 shares during the period. Citigroup Inc.’s holdings in […]
- 03/24/2020
|
Bank of Montreal Can Grows Position in NanoString Technologies Inc (NASDAQ:NSTG)
- Bank of Montreal Can boosted its stake in NanoString Technologies Inc (NASDAQ:NSTG) by 32.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,960 shares of the biotechnology company’s stock after purchasing an additional 1,471 shares during the quarter. Bank of Montreal Can’s holdings in […]
- 03/24/2020
|
Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown
- The coronavirus pandemic is narrowing the avenues open to biotechs for financing their endeavors, according to some industry veterans. “I think that fear
- 03/23/2020
|
ProShare Advisors LLC Sells 1,143 Shares of NanoString Technologies Inc (NASDAQ:NSTG)
- ProShare Advisors LLC decreased its stake in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 8.5% during the fourth quarter, Holdings Channel reports. The firm owned 12,259 shares of the biotechnology company’s stock after selling 1,143 shares during the quarter. ProShare Advisors LLC’s holdings in NanoString Technologies were worth $341,000 as of its most recent filing […]
- 03/23/2020
|
NanoString Technologies Sees Unusually High Options Volume (NASDAQ:NSTG)
- NanoString Technologies Inc (NASDAQ:NSTG) was the target of unusually large options trading activity on Thursday. Traders purchased 1,491 call options on the company. This is an increase of approximately 1,614% compared to the typical volume of 87 call options. In other NanoString Technologies news, SVP David W. Ghesquiere sold 22,000 shares of the firm’s stock […]
- 03/13/2020
|
NanoString Technologies Inc (NASDAQ:NSTG) Shares Acquired by Charles Schwab Investment Management Inc.
- Charles Schwab Investment Management Inc. increased its position in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 2.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 206,285 shares of the biotechnology company’s stock after purchasing an additional 5,528 shares during the quarter. Charles […]
- 03/13/2020
|
Quidel (QDEL) Looks Good: Stock Adds 10.8% in Session
- Quidel (QDEL) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.
- 03/12/2020
|
Quidel (QDEL) Looks Good: Stock Adds 10.8% in Session
|
Global Precision Medicine Market was Estimated to Grow at a Rate of 20.9% During the Forecast Period due to Increasing Focus of Healthcare Sector on Delivering Customized Personal Care: Absolute Markets Insights
- Precision medicine is a healthcare model that enables the dynamic methodology of healthcare, with medical choices, diagnosis, policies, or items being custom-made to the specific patient. Methodologies involved in precision medicine majorly include molecular diagnostics, imaging, and analytics. The global
- 03/11/2020
|
Nanostring Technologies Inc (NSTG) President and CEO R Bradley Gray Sold $–.' million of Shares
|
NanoString Technologies Inc (NASDAQ:NSTG) Shares Purchased by Artisan Partners Limited Partnership
- Artisan Partners Limited Partnership lifted its stake in NanoString Technologies Inc (NASDAQ:NSTG) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 344,660 shares of the biotechnology company’s stock after purchasing an additional 6,230 shares during the quarter. Artisan Partners Limited Partnership […]
- 03/09/2020
|
Edited Transcript of NSTG earnings conference call or presentation 26-Feb-20 9:30pm GMT
- Q4 2019 NanoString Technologies Inc Earnings Call
- 03/07/2020
|
NanoString prices upsized convertible debt offering
- NanoString Technologies (NASDAQ:NSTG) has priced its private upsized $200M (from $175M) 2.625% convertible senior notes due 2025.Initial buyers have a 13-day option to purchase an additional $30M of
- 03/05/2020
|
NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes
- SEATTLE, Wash.--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the pricing of $200 million aggregate principal amount of 2.625% convertible senior notes due 2025 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). NanoString also granted the initial purchasers of the notes a 13-day option to purchase u
- 03/05/2020
|
Edited Transcript of NSTG earnings conference call or presentation 26-Feb-20 9:30pm GMT
- Q4 2019 NanoString Technologies Inc Earnings Call
- 03/05/2020
|
NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes
- NanoString Announces Proposed Private Offering of $175 Million of Convertible Senior Notes
- 03/04/2020
|
David W. Ghesquiere Sells 22,000 Shares of NanoString Technologies Inc (NASDAQ:NSTG) Stock
- NanoString Technologies Inc (NASDAQ:NSTG) SVP David W. Ghesquiere sold 22,000 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $35.09, for a total value of $771,980.00. Following the completion of the sale, the senior vice president now directly owns 76,169 shares of […]
- 03/04/2020
|
Top Ranked Momentum Stocks to Buy for March 3rd
- Top Ranked Momentum Stocks to Buy for March 3rd
- 03/03/2020
|
Top Ranked Momentum Stocks to Buy for March 3rd
- Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 3rd
- 03/03/2020
|
Precision Medicine Market to register over 11% CAGR through 2026: Global Market Insights, Inc.
- Global Market Insights, Inc. has recently added a new report on precision medicine market which estimates the global market valuation for precision medicine will cross US$ 119 billion by 2026. Rising usage of big data analytics in healthcare to manage huge amount of complex data spurs the market growth
- 03/03/2020
|
NanoString Technologies (NASDAQ:NSTG) Upgraded at ValuEngine
- NanoString Technologies (NASDAQ:NSTG) was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating in a report issued on Tuesday, ValuEngine reports. Other equities research analysts also recently issued research reports about the stock. BidaskClub upgraded shares of NanoString Technologies from a “buy” rating to a “strong-buy” rating in a research note […]
- 03/03/2020
|
Veracyte Announces Publication of Nearly 700-Patient Study Using Prosigna Breast Cancer Test to Identify Patients Likely to Benefit from Aggressive Chemotherapy
- Veracyte Announces Publication of Study Using Prosigna Breast Cancer Test to Identify Patients Likely to Benefit from Aggressive Chemotherapy
- 03/02/2020
|
Will NanoString Technologies Continue to Surge Higher?
- As of late, it has definitely been a great time to be an investor in NanoString Technologies.
- 03/02/2020
|
Will NanoString Technologies Continue to Surge Higher?
- As of late, it has definitely been a great time to be an investor in NanoString Technologies.
- 03/02/2020
|
Will NanoString Technologies Continue to Surge Higher?
|
NanoString Technologies Target of Unusually High Options Trading (NASDAQ:NSTG)
- NanoString Technologies Inc (NASDAQ:NSTG) saw some unusual options trading activity on Thursday. Traders acquired 1,491 call options on the stock. This represents an increase of approximately 1,614% compared to the typical volume of 87 call options. Several research analysts have commented on NSTG shares. BidaskClub upgraded shares of NanoString Technologies from a “buy” rating to […]
- 02/29/2020
|
The global single-cell analysis market is projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8%
- New York, Feb. 28, 2020 -- Reportlinker.com announces the release of the report "Single-cell Analysis Market by Cell Type, Product, Technique, Application, End User - Global.
- 02/28/2020
|
NanoString Technologies, Inc. Analysts Are Pretty Bullish On The Stock After Recent Results
- It's been a good week for NanoString Technologies, Inc. (NASDAQ:NSTG) shareholders, because the company has just...
- 02/28/2020
|
NanoString Technologies, Inc. Just Reported And Analysts Have Been Lifting Their Price Targets
- It's been a good week for NanoString Technologies, Inc. (NASDAQ:NSTG) shareholders, because the company has just...
- 02/28/2020
|
NanoString Technologies (NASDAQ:NSTG) Reaches New 52-Week High on Earnings Beat
- NanoString Technologies Inc (NASDAQ:NSTG) reached a new 52-week high on Thursday after the company announced better than expected quarterly earnings. The company traded as high as $35.40 and last traded at $34.89, with a volume of 539529 shares. The stock had previously closed at $32.78. The biotechnology company reported ($0.59) earnings per share for the […]
- 02/28/2020
|
Jounce Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
- - On track to initiate Phase 2 SELECT trial in mid-2020 and present preliminary efficacy and related biomarker data from Phase 2 EMERGE trial in 2H 2020 - - Ended 2019.
- 02/27/2020
|
NanoString: 4Q Earnings Snapshot
- SEATTLE (AP) _ NanoString Technologies Inc. (NSTG) on Wednesday reported fourth-quarter net income of $24 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Seattle-based company said it had net income of 61 cents. Losses, adjusted for non-recurring gains, came to 14 cents per share. The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share. The maker of diagnostic systems for the analysis of genomic information posted revenue of $36.9 million in the period. For the year, the company reported that its loss narrowed to $40.7 million, or $1.18 per share. Revenue was reported as $125.6 million. NanoString shares have risen 18% since the beginning of the year. The stock has climbed 38% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NSTG at https://www.zacks.com/ap/NSTG
- 02/27/2020
|
NanoString: 4Q Earnings Snapshot
- SEATTLE (AP) _ NanoString Technologies Inc. (NSTG) on Wednesday reported fourth-quarter net income of $24 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Seattle-based company said it had net income of 61 cents. The average estimate of four analysts surveyed
- 02/27/2020
|
NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q4 2019 Results - Earnings Call Transcript
- NanoString Technologies, Inc. (NASDAQ:NSTG) Q4 2019 Earnings Conference Call February 26, 2020 04:30 PM ET Company Participants Doug Farrell - Vice President-In
- 02/27/2020
|
Stocks That Hit 52-Week Highs On Thursday
|
NanoString Technologies (License of nCounter Diagnostic Assets and Rights) Company Profile: Acquisition & Investors | PitchBook
- Information on acquisition, funding, investors, and executives for NanoString Technologies (License of nCounter Diagnostic Assets and Rights). Use the PitchBook Platform to explore the full profile.
- 02/26/2020
|
NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook
- NanoString releases operating results for fourth quarter and fiscal 2019.
- 02/26/2020
|
NanoString Sees FY20 Sales $124M-$131M A Increase Of 20%-26% Up YoY
|
NanoString Technologies (NSTG) to Release Earnings on Wednesday
- NanoString Technologies (NASDAQ:NSTG) is scheduled to post its quarterly earnings results after the market closes on Wednesday, February 26th. Analysts expect NanoString Technologies to post earnings of ($0.60) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link. NASDAQ NSTG opened at $33.41 […]
- 02/24/2020
|
California Public Employees Retirement System Cuts Stake in NanoString Technologies Inc (NASDAQ:NSTG)
- California Public Employees Retirement System reduced its stake in NanoString Technologies Inc (NASDAQ:NSTG) by 6.7% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 77,762 shares of the biotechnology company’s stock after selling 5,581 shares during the quarter. California Public Employees Retirement System owned 0.22% of NanoString Technologies […]
- 02/22/2020
|
NanoString Technologies (NASDAQ:NSTG) Lifted to Strong-Buy at BidaskClub
- NanoString Technologies (NASDAQ:NSTG) was upgraded by stock analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued on Saturday, BidAskClub reports. NSTG has been the subject of a number of other reports. Stifel Nicolaus initiated coverage on NanoString Technologies in a report on Thursday, November 14th. They issued a […]
- 02/22/2020
|
Acadian Asset Management LLC Sells 119,250 Shares of NanoString Technologies Inc (NASDAQ:NSTG)
- Acadian Asset Management LLC trimmed its position in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 57.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 89,360 shares of the biotechnology company’s stock after selling 119,250 shares during the period. Acadian Asset Management LLC’s holdings in NanoString Technologies were worth $2,486,000 as of its […]
- 02/22/2020
|
Independent Advisor Alliance Invests $872,000 in NanoString Technologies Inc (NASDAQ:NSTG)
- Independent Advisor Alliance purchased a new position in NanoString Technologies Inc (NASDAQ:NSTG) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 31,331 shares of the biotechnology company’s stock, valued at approximately $872,000. Independent Advisor Alliance owned approximately 0.09% of […]
- 02/21/2020
|
Single-cell Analysis Market Worth $5.6 Billion by 2025 - Exclusive Report by MarketsandMarkets™
- According to the new market research report "Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User - Global Forecasts to 2025&
- 02/21/2020
|
J. Chad Brown Sells 1,458 Shares of NanoString Technologies Inc (NASDAQ:NSTG) Stock
- NanoString Technologies Inc (NASDAQ:NSTG) SVP J. Chad Brown sold 1,458 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $33.51, for a total transaction of $48,857.58. Following the transaction, the senior vice president now owns 13,754 shares of the company’s stock, […]
- 02/21/2020
|
NanoString Highlights Groundbreaking Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology (AGBT) Conference
- NanoString Highlights Groundbreaking Spatial Genomics Research at 2020 Advances in Genome Biology and Technology (AGBT) Conference
- 02/20/2020
|
NanoString Technologies Highlights Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology Conference
|
NanoString Technologies (NSTG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/19/2020
|
NanoString Technologies (NSTG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/19/2020
|
NanoString to Present at the 40th Annual Cowen Healthcare Conference
- NanoString to present at the 40th annual Cowen Healthcare conference.
- 02/18/2020
|
Nanostring Technologies Inc (NSTG) President and CEO R Bradley Gray Sold $67—,6…… of Shares
|
Broadfin Capital, LLC Buys Staar Surgical Co, Alkermes PLC, Quotient, Sells Allergan PLC, Nevro ...
|
NanoString Technologies Inc (NASDAQ:NSTG) Stock Holdings Lessened by Cutler Group LP
- Cutler Group LP cut its holdings in NanoString Technologies Inc (NASDAQ:NSTG) by 77.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 5,400 shares of the biotechnology company’s stock after selling 18,400 shares during the period. Cutler Group LP’s holdings in NanoString Technologies were worth $150,000 as […]
- 02/14/2020
|
Nanostring Technologies Inc (NSTG) President and CEO R Bradley Gray Sold $6'7,4…… of Shares
|
The Global Transplant Diagnostics Market to Generate Revenues of Around $2 Billion During the Period 2020 −2025 - Market Research by Arizton
- According to Arizton's recent research report, Transplant Diagnostics Market - Global Outlook and Forecast 2020-2025 is expected to grow at a CAGR of approximately 7% during the period 2019−2025.
- 02/11/2020
|
NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020
- NanoString Announces Q4-2019 Quarterly Conference Call
- 02/10/2020
|
Stocks Showing Rising Market Leadership: NanoString Technologies Earns 86 RS Rating
|
Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announces Research Collaboration with NanoString Technologies
- Jounce Therapeutics, Inc. (JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced new data on the identification of the predictive biomarker to be used for patient selection in the SELECT clinical trial of vopratelimab (vopra), in addition to a research collaboration with NanoString (NSTG). The new data introduces TISvopra, a baseline RNA signature with a threshold optimized for the emergence of ICOS hi CD4 T cells, a vopratelimab pharmacodynamic biomarker not associated with PD-1 inhibitor therapy.
- 02/06/2020
|
Jounce Highlights Presentation Of New Vopratelimab Predictive Biomarker Data At ASCO-SITC Symposium
|
Nanostring Technologies Inc (NSTG) CFO K Thomas Bailey Sold $7—7,……' of Shares
|
Head to Head Survey: NanoString Technologies (NASDAQ:NSTG) vs. Champions Oncology (NASDAQ:CSBR)
- NanoString Technologies (NASDAQ:NSTG) and Champions Oncology (NASDAQ:CSBR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Insider & Institutional Ownership 49.6% of Champions Oncology shares are held by institutional investors. 5.1% […]
- 02/04/2020
|
Is NanoString Technologies, Inc. (NASDAQ:NSTG) A Volatile Stock?
- If you own shares in NanoString Technologies, Inc. (NASDAQ:NSTG) then it's worth thinking about how it contributes to...
- 02/03/2020
|
Global Precision Medicine Market 2016 to 2025 - Featuring Eagle Genomics, Biocrates Life Sciences, Teva Pharmaceuticals & Quest Diagnostics Among Others - ResearchAndMarkets.com
- The "Precision Medicine Market By Technology, By Application, and By End-User: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
- 01/27/2020
|
Conestoga Capital Advisors LLC Grows Position in NanoString Technologies Inc (NASDAQ:NSTG)
- Conestoga Capital Advisors LLC increased its position in shares of NanoString Technologies Inc (NASDAQ:NSTG) by 41.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 21,770 shares of the biotechnology company’s stock after buying an additional 6,425 shares during the quarter. Conestoga Capital Advisors LLC […]
- 01/25/2020
|
Exchange Traded Concepts LLC Makes New $76,000 Investment in NanoString Technologies Inc (NASDAQ:NSTG)
- Exchange Traded Concepts LLC bought a new position in NanoString Technologies Inc (NASDAQ:NSTG) in the fourth quarter, Holdings Channel.com reports. The fund bought 2,740 shares of the biotechnology company’s stock, valued at approximately $76,000. A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. […]
- 01/25/2020
|
Nanostring Technologies Inc (NSTG) President and CEO R Bradley Gray Sold $599,8…… of Shares
|
Is NanoString Technologies (NASDAQ:NSTG) Weighed On By Its Debt Load?
- Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- 01/20/2020
|
David W. Ghesquiere Sells 19,279 Shares of NanoString Technologies Inc (NASDAQ:NSTG) Stock
- NanoString Technologies Inc (NASDAQ:NSTG) SVP David W. Ghesquiere sold 19,279 shares of the business’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $29.07, for a total transaction of $560,440.53. Following the completion of the sale, the senior vice president now owns 54,469 shares in the company, […]
- 01/16/2020
|
